CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

BioPharma Dive
Original article

Draig bags another $65M to speed testing of brain drugs

Positive
AI Analysis

Summary

Draig Pharmaceuticals secured $65M in funding to support mid-stage trials of a brain drug candidate for major depressive disorder, which the company describes as having best-in-disease potential.

Clinical Trial Data

Phase

Phase 2

Importance:5/10
Sentiment:
0.60
fundingmid-stage trialsmajor depressive disorderCNS
Related Companies

Read the original article

Published by BioPharma Dive on July 14, 2026 1:59 PM

Read Original